FDA's Concerns Delay Action on Experimental Drug Bill

February 14, 2018

A bill to make it easier for seriously ill patients to get access to experimental drugs is being held up over questions concerning who is considered sick enough to be granted special access to unapproved medicines, lawmakers told Bloomberg Law on Feb. 6.

Related Stories